TITLE

Clomiphene citrate improved testosterone levels in hypogonadal, overweight men

PUB. DATE
December 2010
SOURCE
Endocrine Today;Dec2010, Vol. 8 Issue 12, p15
SOURCE TYPE
Newspaper
DOC. TYPE
Article
ABSTRACT
The article focuses on a study which revealed that clomiphene citrate can improve the testosterone levels in hypogonadal, overweight men, that was presented at the conference of the American Society for Reproductive Medicine on October 23-27, 2010 in Denver, Colorado.
ACCESSION #
55692361

 

Related Articles

  • Clomiphene may offer alternative for treating low T. Overmyer, Mac // Urology Times;Mar2011, Vol. 39 Issue 3, p26 

    The article informs that researcher Darren Katz has found that clomiphene citrate (Clomid) could be an effective therapeutic option for men with hypogonadium. Katz said that clomiphene is a well-tolerated drug that may provide an efficacious alternative to tesosterone. It has been stated that...

  • Testosterone, clomiphene yield similar satisfaction. Krader, Cheryl Guttman // Urology Times;Aug2014, Vol. 42 Issue 9, p14 

    The article focuses on a recent retrospective study from Baylor College of Medicine, Houston, which found that similar satisfaction levels as age-matched men treated with testosterone injections are reported by symptomatic hypogonadal men treated with clomiphene citrate, despite having...

  • The safety and efficacy of clomiphene citrate in hypoandrogenic and subfertile men. Patel, D P; Brant, W O; Myers, J B; Presson, A P; Johnstone, E B; Dorais, J A; Aston, K I; Carrell, D T; Hotaling, J M // International Journal of Impotence Research;Nov/Dec2015, Vol. 27 Issue 6, p221 

    Our objective was to evaluate the safety and efficacy of clomiphene citrate (CC) in infertile and hypoandrogenic men through a retrospective study between September 2013 and May 2014. We identified 47 men between 18 and 55 years placed on 50 mg CC every other day. We evaluated the effect of CC...

  • Custom prescriptions. O'Connor, Patrick G.; Berkowitz, Henry D.; Cohn, Peter F.; Gorman, B. David; Lief, Philip D.; Mishell Jr., Daniel R.; Nichols, Gwen L.; Rigsby, Michael O.; Ryan, Michael E. // Cortlandt Forum;12/20/97, Vol. 10 Issue 12, p119 

    Provides information on where sublingual testosterone tablets can be obtained.

  • Clomifene.  // Reactions Weekly;6/1/2013, Issue 1455, p11 

    The article describes the case of a 30-year-old woman who experienced bilateral tubal ampullary pregnancy while undergoing clomifene therapy for fertility enhancement.

  • Pilot study of the transdermal application of testosterone gel to the penile skin for the treatment of hypogonadotropic men with erectile dysfunction. Schultheiss, Dirk; Hiltl, Dirk-Michael; Meschi, Mohammad R.; Machtens, Stefan A.; Truss, Michael C.; Stief, Christian G.; Jonas, Udo // World Journal of Urology;Dec2000, Vol. 18 Issue 6, p431 

    Androgens influence important central and peripheral mechanisms of the erectile system. The relevance of a moderate decrease of serum testosterone level for erectile dysfunction (ED) has not been clarified so far. The aim of our study was to offer an easy transcutaneous method of androgen...

  • Dihydrotestosterone: Hormone or Autocrine--Paracrine Signal? Swerdloff, Ronald S.; Wang, Christina // Annals of Internal Medicine;11/16/2010, Vol. 153 Issue 10, p678 

    The authors reflect on the risk-benefit profile of testosterone replacement. They argue that the findings offer insights on the possible efficacy of future synthetic androgen receptor modulators which will share the anabolic effects on muscle and fat as well as the sparing effects on the...

  • A risk-benefit assessment of treatment with finasteride in benign prostatic hyperplasia. Ekman, P. // Drug Safety;Mar1998, Vol. 18 Issue 3, p161 

    As an androgen target organ, the prostate gland has the almost unique characteristic of being less sensitive to testosterone than to its metabolite 5α-dihydrotestosterone (5α-DHT). The conversion of testosterone to 5α-DHT is induced by the enzyme 5α-reductase. By blocking the...

  • Dexamethasone / human chorionic gonadotrophin (hCG) and dexamethasone / nafarelin as a valid diagnostic tests in reproductive aged women with polycystic ovarian syndrome (PCOS). Hajder, E.; Hajder, M. // HealthMed;Mar2010, Vol. 4 Issue 1, p87 

    Introduction. Hyperandrogenism is a functional, diagnostic and therapeutic problem of women in reproductive age. The aim of this study was to determine the validity of dexamethasone-human chorion gonadotrophin (DEXA/hCG) and dexamethasone- nafarelin (DEXA/N) testing in the differential...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics